Patient Compliance: Clinical Trials

47 trials for Patient Compliance, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

47 completed. 47 Phase 2, 8 Phase 1, 6 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 247Completed 47
Phase 18Completed 8
Phase 36Completed 6

Follow Patient Compliance: new trials by email Literature Review of Patient Compliance trials Research Report on Patient Compliance

Trials (filtered) newest first · largest first

All 47 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Preventing Medication Mismanagement in People Living With Dementia Through Automated Medication Dispensing With Facial Recognition and Video Observation
HiDO-ALZ - Alzheimer Disease, Dementia
Phase 2CompletedHiDO Technologies502024-09-052026-10-07
Heart Failure Polypill at a Safety Net Hospital
Heart failure polypill, Control Rx - Heart Failure With Reduced Ejection Fraction, HIV Infections
Phase 2CompletedUniversity of California, San Francisco352024-02-272025-12-31
Project Engage: Oral PrEP Acceptability
emtricitabine/tenofovir alafenamide, Emtricitabine / Tenofovir Disoproxil Oral Tablet - Acceptability of Health Care, Adherence, Medication
Phase 2CompletedEastern Virginia Medical School3302022-06-212024-07-29
Symptom-driven ICS/LABA Therapy for Adolescent Patients With Asthma Non-adherent to Daily Maintenance Inhalers
Maintenance ICS and Symptom Driven SABA, Symptom-driven budesonide/formoterol combination - Asthma in Children, Nonadherence, Medication
Phase 1 / Phase 2CompletedWashington University School of Medicine552022-04-012026-08-19
Medication Responsiveness in Parkinson's Disease
CloudUPDRS - Tapping Task - Parkinson Disease, Medication Compliance
Phase 2CompletedKU Leuven332019-07-252021-01-27
Stroke Minimization Through Additive Anti-atherosclerotic Agents in Routine Treatment
Polycap - Atherosclerosis, Adherence, Medication
Phase 2CompletedNorthern California Institute of Research and Education1482019-02-142023-12-20
Role of Pegylated Interferon in Combination With DAAs to Cure Hepatitis C As Soon As Possible - Hepatitis C [ASAP-C]
Sofosbuvir, Daclatasvir, Pegylated Interferon alfa-2a - Hepatitis C, Chronic
Phase 2 / Phase 3CompletedJohns Hopkins Bloomberg School of Public Health1502018-02-022021-05-18
Phase II Study Evaluating the Efficacy of Tacrolimus Extended Release Tablets to Twice Daily Tacrolimus Dosing Regimen
Envarsus - Heart Transplant Rejection, Graft Failure
Phase 2CompletedBaylor Research Institute502017-12-042025-10-08
Project Impact 2: A Culturally Tailored Smoking Cessation Intervention for Latino Smokers
Nicotine Patch, Questionnaires, Carbon Monoxide (CO) Test - Tobacco Use Cessation, Cancer Prevention
Phase 1 / Phase 2CompletedM.D. Anderson Cancer Center262015-11-022020-03-10
Study to Evaluate Treatment Compliance, Efficacy and Safety of an Improved Deferasirox Formulation (Granules) in Pediatric Patients (2-<18 Years Old) With Iron Overload
Deferasirox granule formulation, Deferasirox DT formulation - Transfusion-dependent Anemia
Phase 2CompletedNovartis Pharmaceuticals2242015-10-212024-09-19
Directly Observed Therapy for HCV in Chennai, India
Sofosbuvir, Pegylated Interferon alfa-2a, Ribavirin - Hepatitis C, Chronic
Phase 2CompletedJohns Hopkins Bloomberg School of Public Health502015-09-012021-04-15
Study to Test the Efficacy of Online Education to Increase Safe Use of Opioid Medication.
Experimental - Medication Adherence
Phase 2CompletedInflexxion, Inc.1762012-09-012014-05-19
Exercise Interventions in Parkinson's Disease
Exercise Programme, Hand Writing programme - Parkinson's Disease
Phase 2CompletedOxford Brookes University1052011-09-012014-10-21
Alprazolam as Conscious Sedation for Upper Gastrointestinal Endoscopy
Oral alprazolam, Sublingual alprazolam, Oral placebo - Diagnostic Esophagogastroduodenoscopy
Phase 2 / Phase 3CompletedIsfahan University of Medical Sciences2202011-09-012013-10-18
Nurse Delivered Cell Phone Adherence Intervention (Pick It UP)
Adherence Counseling, General Health Counseling, Text Messages - Medication Adherence
Phase 1 / Phase 2CompletedUniversity of Connecticut6002011-07-012014-12-03
Adaptive Goal-Directed Adherence Tracking and Enhancement
AGATE, SASED - Alcohol Abuse
Phase 2CompletedTalaria, Inc1362011-07-012014-05-13
Holistic Approaches to Depression
Yoga, Healthy Living Workshop - Depression
Phase 2CompletedButler Hospital1212011-06-012016-04-13
Reliability, Safety and Usability of the Transplantation Sensor System Combined With Myfortic® in Adult Kidney Transplant Patients
ECMPS-IEM - Detection Accuracy, Patient Compliance
Phase 2CompletedNovartis Pharmaceuticals302011-05-102017-02-23
Reducing Heavy Drinking to Optimize HIV/AIDS Treatment and Prevention
Naltrexone, Placebo + Medication Management/Medication Coaching - Reduction in Heavy Drinking in Patients With HIV
Phase 2 / Phase 3CompletedYale University512011-04-012019-03-21
Pilot Program to Improve Statin Adherence and Lower Cholesterol in Older Adults
Medication adherence intervention, Attention-control - Hypercholesterolemia, Medication Adherence
Phase 1 / Phase 2CompletedUniversity of Missouri-Columbia432010-10-012016-10-24

Showing 20 of 47. Sign in to see all of them.

Narrower conditions

Medication Adherence (13)  ·  Health Education (12)  ·  Alcoholism (4)  ·  Directly Observed Therapy (4)  ·  HIV Infections (4)  ·  Acquired Immunodeficiency Syndrome (3)  ·  Diabetes Mellitus (3)  ·  Hyperlipidemias (3)  ·  Motor Activity (3)  ·  Atherosclerosis (2)  ·  Behavior (2)  ·  Cardiovascular Diseases (2)  ·  Depression (2)  ·  Hepatitis C, Chronic (2)

Broader conditions

Health Behavior (47)  ·  Treatment Adherence and Compliance (47)  ·  Patient Acceptance of Health Care (46)  ·  Behavior (45)  ·  Medication Adherence (16)  ·  Adherence Interventions (12)  ·  Metabolic Diseases (10)  ·  Nutritional and Metabolic Diseases (10)  ·  Infections (8)  ·  Mental Disorders (8)  ·  Nervous System Diseases (8)  ·  Blood-Borne Infections (7)  ·  Communicable Diseases (7)  ·  Immune System Diseases (7)

Interventions

Exercise (3)  ·  Sofosbuvir (2)  ·  peginterferon alfa-2a (2)  ·  Alprazolam (1)  ·  Carbon Monoxide (1)  ·  Citalopram (1)  ·  Contracts (1)  ·  Counseling (1)  ·  Deferasirox (1)  ·  Diet Therapy (1)  ·  Emtricitabine (1)  ·  Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination (1)  ·  Fluoxetine (1)  ·  Lopinavir (1)  ·  Meditation (1)

Sponsors

Butler Hospital (2)  ·  Johns Hopkins Bloomberg School of Public Health (2)  ·  Kovacs Foundation (2)  ·  Novartis Pharmaceuticals (2)  ·  San Diego State University (2)  ·  US Department of Veterans Affairs (2)  ·  University of California, San Francisco (2)  ·  VA Office of Research and Development (2)  ·  Yale University (2)  ·  Baylor Research Institute (1)  ·  Brigham and Women's Hospital (1)  ·  Chestnut Hill Health System (1)  ·  Eastern Virginia Medical School (1)  ·  Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1)  ·  Georgetown University (1)

Countries

United States (32)  ·  India (3)  ·  Belgium (2)  ·  Canada (2)  ·  Iran (2)  ·  South Africa (2)  ·  Spain (2)  ·  Bulgaria (1)  ·  Egypt (1)  ·  France (1)  ·  Ghana (1)  ·  Hungary (1)  ·  Italy (1)  ·  Lebanon (1)  ·  Malaysia (1)

Top investigators

Carl J Stepnowsky, PhD (2)  ·  Ahmad Shavakhi, M.D. (1)  ·  Akram Pourshams, PhD (1)  ·  Alexander Dromerick, MD (1)  ·  Alice Nieuwboer (1)  ·  Ana Abrantes, PhD (1)  ·  Antonio Ruiz, MD (1)  ·  Carlos Isanta, MD (1)  ·  Celia Albaladejo, MD (1)  ·  Charles Flexner, MD (1)  ·  Chelsea S. Kidwell, MD (1)  ·  Christina D Adams, PhD (1)  ·  Colette DeJong, MD (1)

Results publications

PMID 11764222, PMID 16818482, PMID 17441783, PMID 17513285, PMID 19122865, PMID 19255065, PMID 19597072, PMID 19928484, PMID 20105415, PMID 20147875, PMID 20192725, PMID 20598843, PMID 21443297, PMID 23122489, PMID 23186301, PMID 23248342, PMID 23816039, PMID 23823651, PMID 24212451, PMID 24977401, PMID 25890676, PMID 25909320, PMID 26631085, PMID 26908586, PMID 27590273, PMID 27837101, PMID 28719029, PMID 29065955, PMID 29540234, PMID 30633744, PMID 31141465, PMID 36602886, PMID 37268772, PMID 37734804, PMID 38588457, PMID 39082406, PMID 39208136, PMID 40118491

NIH funding

R01DA026727 (2), K01CA160670 (1), K23DA019950 (1), KL2TR002346 (1), P60AR036308 (1), R01AA013957 (1), R01AA018923 (1), R01AR044020 (1), R01DK072325 (1), R01MH063011 (1), R01NR012005 (1), R01NR012962 (1), R21AT003102 (1), U54NS057405 (1), UL1TR002345 (1)